CXCR4 expression on circulating pan-cytokeratin positive cells is associated with survival in patients with advanced non-small cell lung cancer
<p>Abstract</p> <p>Background</p> <p>The CXC chemokine, CXCL12, and its receptor, CXCR4 promote metastases of a variety of solid tumors, including non-small cell lung cancer (NSCLC). The expression of CXCR4 on tumor cells may represent a critical biomarker for their pro...
Main Authors: | Dubinett Steven M, Burdick Marie D, Figlin Robert A, Reckamp Karen L, Elashoff Robert M, Strieter Robert M |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2009-06-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/9/213 |
Similar Items
-
Stromal Derived Factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis
by: Reckamp Karen, et al.
Published: (2006-11-01) -
Pan cytokeratin expression by meningiomas of the brain
by: S. I. Tertishniy, et al.
Published: (2015-04-01) -
Overexpression of CCL-21/Secondary Lymphoid Tissue Chemokine in Human Dendritic Cells Augments Chemotactic Activities for Lymphocytes and Antigen Presenting Cells
by: Strieter Robert, et al.
Published: (2003-11-01) -
Identifying squamous cell carcinoma and cytokeratin-derived amyloid with pan-cytokeratin AE1/AE3 during Mohs micrographic surgery
by: Kirk Sidey, MD, MBA, et al.
Published: (2020-08-01) -
Detection of circulating tumor cells in hepatocellular carcinoma using antibodies against asialoglycoprotein receptor, carbamoyl phosphate synthetase 1 and pan-cytokeratin.
by: Jun Li, et al.
Published: (2014-01-01)